Search
for
Sort by
Research 61–90 of 1000+
- Paraneoplastic alopecia associated with internal malignancies in the cat
- Epidermal Notch1 recruits innate lymphoid cells to orchestrate normal skin repair
- National scientific medical meeting 1996 abstracts
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum
- Viral-associated trichodysplasia spinulosa: a case with electron microscopic and molecular detection of the trichodysplasia spinulosa-associated human polyomavirus
- Commonalities Between COVID-19 and Radiation Injury
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report
- PBX1-SIRT1 Positive Feedback Loop Attenuates ROS-Mediated HF-MSC Senescence and Apoptosis
- Oral Signs of Hematologic Disease
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- Runx Family Genes in Tissue Stem Cell Dynamics
- Rejuvenation: an integrated approach to regenerative medicine
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- Cytostatics and immunosuppressive drugs
- Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases
- CUTANEOUS T-CELL LYMPHOMA
- Toxic Epidermal Necrolysis
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Cutaneous Reactions to Drugs
- Aldesleukin
- PHILADELPHIA DERMATOLOGICAL SOCIETY
- Cutaneous reactions to recombinant cytokine therapy
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Dermatological drugs, topical agents, and cosmetics
- The pharmacology of methotrexate
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner